Purification of plasmodium sporozoites enhances parasite-specific CD8+ T cell responses

Infection and Immunity

Volumn 84, Issue 8, 2016, Pages 2233-2242

  Billman, Zachary P ^a   Seilie, Annette M ^a   Murphya, Sean C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; SPOROZOITE VACCINE; EPITOPE; MALARIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; LIVER; MOUSE; NONHUMAN; PARASITE LOAD; PLASMODIUM YOELII; PRIORITY JOURNAL; SALIVARY GLAND; SENSITIZATION; SPOROZOITE; VACCINATION; ANIMAL; DISEASE MODEL; IMMUNIZATION; IMMUNOLOGY; MALARIA; PARASITOLOGY; PLASMODIUM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNIZATION; MALARIA; MALARIA VACCINES; MICE; PLASMODIUM; SPOROZOITES;

EID: 84979787290     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01439-15     Document Type: Article

References (59)

1. Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG, Jr. 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/ AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 200:337-346. http://dx.doi.org/10.1086 /600120.
2. Ndungu FM, Mwacharo J, Kimani D, Kai O, Moris P, Jongert E, Vekemans J, Olotu A, Bejon P. 2012. A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E. PLoS One 7:e52870. http://dx.doi.org/10.1371/journal.pone.0052870.
3. Barbosa A, Naniche D, Aponte JJ, Manaca MN, Mandomando I, Aide P, Sacarlal J, Renom M, Lafuente S, Ballou WR, Alonso PL. 2009. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Infect Immun 77:4502- 4509. http://dx.doi.org/10.1128/IAI.00442-09.
4. Pichyangkul S, Kum-Arb U, Yongvanitchit K, Limsalakpetch A, Gettayacamin M, Lanar DE, Ware LA, Stewart VA, Heppner DG, Mettens P, Cohen JD, Ballou WR, Fukuda MM. 2008. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Infect Immun 76:229-238. http://dx.doi.org/10.1128/IAI.00977-07.
5. Nussenzweig RS, Vanderberg J, Most H, Orton C. 1967. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216:160 -162. http://dx.doi.org/10.1038 /216160a0.
6. Clyde DF, Most H, McCarthy VC, Vanderberg JP. 1973. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266: 169-177. http://dx.doi.org/10.1097/00000441-197309000-00002.
7. Mueller AK, Labaied M, Kappe SH, Matuschewski K. 2005. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433:164-167. http://dx.doi.org/10.1038/nature03188.
8. Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K. 2009. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 199:899-903. http://dx.doi.org/10.1086/597121.
9. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R. 2009. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468-477. http://dx.doi.org /10.1056/NEJMoa0805832.
10. Doolan DL, Hoffman SL. 2000. The complexity of protective immunity against liver-stage malaria. J Immunol 165:1453-1462. http://dx.doi.org /10.4049/jimmunol.165.3.1453.
11. Conteh S, Chattopadhyay R, Anderson C, Hoffman SL. 2010. Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route. PLoS One 5:e8947. http://dx.doi.org/10.1371 /journal.pone.0008947.
12. Leitner WW, Bergmann-Leitner ES, Angov E. 2010. Comparison of Plasmodium berghei challenge models for the evaluation of preerythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Malar J 9:145. http://dx.doi.org/10.1186/1475-2875-9-145.
13. Ploemen IH, Chakravarty S, GJ van Gemert Annoura T, Khan SM, Janse CJ, Hermsen CC, Hoffman SL, Sauerwein RW. 2013. Plasmodium liver load following parenteral sporozoite administration in rodents. Vaccine 31:3410-3416. http://dx.doi.org/10.1016/j.vaccine.2012.09.080.
14. Sheehy SH, Spencer AJ, Douglas AD, Sim BK, Longley RJ, Edwards NJ, Poulton ID, Kimani D, Williams AR, Anagnostou NA, Roberts R, Kerridge S, Voysey M, James ER, Billingsley PF, Gunasekera A, Lawrie AM, Hoffman SL, Hill AV. 2013. Optimising controlled human malaria infection studies using cryopreserved parasites administered by needle and syringe. PLoS One 8:e65960. http://dx.doi.org/10.1371/journal.pone .0065960.
15. Laurens MB, Billingsley P, Richman A, Eappen AG, Adams M, Li T, Chakravarty S, Gunasekera A, Jacob CG, Sim BK, Edelman R, Plowe CV, Hoffman SL, Lyke KE. 2013. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection. PLoS One 8:e68969. http: //dx.doi.org/10.1371/journal.pone.0068969.
16. Hopp CS, Sinnis P. 2015. The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin. Ann N Y Acad Sci 1342: 37-43. http://dx.doi.org/10.1111/nyas.12661.
17. Ockenfels B, Michael E, McDowell MA. 2014. Meta-analysis of the effects of insect vector saliva on host immune responses and infection of vectortransmitted pathogens: a focus on leishmaniasis. PLoS Negl Trop Dis 8:e3197. http://dx.doi.org/10.1371/journal.pntd.0003197.
18. Waitayakul A, Somsri S, Sattabongkot J, Looareesuwan S, Cui L, Udomsangpetch R. 2006. Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Acta Trop 98:66-73. http://dx.doi.org/10.1016/j.actatropica.2006.02.004.
19. Fontaine A, Fusai T, Briolant S, Buffet S, Villard C, Baudelet E, Pophillat M, Granjeaud S, Rogier C, Almeras L. 2012. Anopheles salivary gland proteomes from major malaria vectors. BMC Genomics 13: 614. http://dx.doi.org/10.1186/1471-2164-13-614.
20. King JG, Vernick KD, Hillyer JF. 2011. Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva. J Biol Chem 286:40824-40834. http://dx.doi.org/10 .1074/jbc.M111.280552.
21. Demeure CE, Brahimi K, Hacini F, Marchand F, Peronet R, Huerre M, St-Mezard P, Nicolas JF, Brey P, Delespesse G, Mecheri S. 2005. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 174: 3932-3940. http://dx.doi.org/10.4049/jimmunol.174.7.3932.
22. Schneider BS, Mathieu C, Peronet R, Mecheri S. 2011. Anopheles stephensi saliva enhances progression of cerebral malaria in a murine model. Vector Borne Zoonotic Dis 11:423-432. http://dx.doi.org/10.1089 /vbz.2010.0120.
23. Depinay N, Hacini F, Beghdadi W, Peronet R, Mecheri S. 2006. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176:4141-4146. http://dx.doi.org/10.4049 /jimmunol.176.7.4141.
24. Guilbride DL, Gawlinski P, Guilbride PD. 2010. Why functional preerythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS One 5:e10685. http://dx.doi.org/10.1371/journal.pone.0010685.
25. Miller JL, Sack BK, Baldwin M, Vaughan AM, Kappe SH. 2014. Interferon- mediated innate immune responses against malaria parasite liver stages. Cell Rep 7:436-447. http://dx.doi.org/10.1016/j.celrep.2014.03 .018.
26. Schmidt NW, Butler NS, Badovinac VP, Harty JT. 2010. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 6:e1000998. http://dx.doi.org/10.1371/journal.ppat.1000998.
27. Murphy SC, Kas A, Stone BC, Bevan MJ. 2013. A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc Natl Acad Sci U S A 110:6055-6060. http://dx.doi.org /10.1073/pnas.1303834110.
28. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V. 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444:937-940. http://dx.doi.org/10.1038/nature05361.
29. Gruner AC, Mauduit M, Tewari R, Romero JF, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Crisanti A, Sinnis P, Mazier D, Corradin G, Snounou G, Renia L. 2007. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2:e1371. http://dx.doi.org/10.1371/journal.pone.0001371.
30. Kumar KA, Baxter P, Tarun AS, Kappe SH, Nussenzweig V. 2009. Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS One 4:e4480. http://dx .doi.org/10.1371/journal.pone.0004480.
31. Mauduit M, Tewari R, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Snounou G, Renia L, Gruner AC. 2010. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 78:2182- 2188. http://dx.doi.org/10.1128/IAI.01415-09.
32. Mauduit M, Gruner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, Franetich JF, Crisanti A, Mazier D, Snounou G, Renia L. 2009. A role for immune responses against non-CS components in the crossspecies protection induced by immunization with irradiated malaria sporozoites. PLoS One 4:e7717. http://dx.doi.org/10.1371/journal.pone .0007717.
33. Kennedy M, Fishbaugher ME, Vaughan AM, Patrapuvich R, Boonhok R, Yimamnuaychok N, Rezakhani N, Metzger P, Ponpuak M, Sattabongkot J, Kappe SH, Hume JC, Lindner SE. 2012. A rapid and scalable density gradient purification method for Plasmodium sporozoites. Malar J 11:421. http://dx.doi.org/10.1186/1475-2875-11-421.
34. Murphy SC, Prentice JL, Williamson K, Wallis CK, Fang FC, Fried M, Pinzon C, Wang R, Talley AK, Kappe SH, Duffy PE, Cookson BT. 2012. Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am J Trop Med Hyg 86:383-394. http://dx.doi.org/10.4269 /ajtmh.2012.10-0658.
35. Miller JL, Murray S, Vaughan AM, Harupa A, Sack B, Baldwin M, Crispe IN, Kappe SH. 2013. Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS One 8:e60820. http://dx.doi.org/10.1371 /journal.pone.0060820.
36. Donovan MJ, Messmore AS, Scrafford DA, Sacks DL, Kamhawi S, McDowell MA. 2007. Uninfected mosquito bites confer protection against infection with malaria parasites. Infect Immun 75:2523-2530. http://dx.doi.org/10.1128/IAI.01928-06.
37. Kebaier C, Voza T, Vanderberg J. 2010. Neither mosquito saliva nor immunity to saliva has a detectable effect on the infectivity of Plasmodium sporozoites injected into mice. Infect Immun 78:545-551. http://dx.doi .org/10.1128/IAI.00807-09.
38. Nganou-Makamdop K, Sauerwein RW. 2013. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better? Trends Parasitol 29:304-310. http://dx.doi.org/10.1016/j.pt.2013.03.008.
39. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M, Richman A, Velmurugan S, Reyes S, Li M, Tucker K, Ahumada A, Ruben AJ, Li T, Stafford R, Eappen AG, Tamminga C, Bennett JW, Ockenhouse CF, Murphy JR, Komisar J, Thomas N, Loyevsky M, Birkett A, Plowe CV, Loucq C, Edelman R, Richie TL, Seder RA, Hoffman SL. 2011. Live attenuated malaria vaccine designed to protect through hepatic CD8(+)T cell immunity. Science 334:475-480. http://dx.doi.org/10.1126/science .1211548.
40. Montalvao F, Garcia Z, Celli S, Breart B, Deguine J, Van Rooijen N, Bousso P. 2013. The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J Clin Investig 123:5098-5103. http://dx .doi.org/10.1172/JCI70972.
41. Pradel G, Frevert U. 2001. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 33: 1154-1165. http://dx.doi.org/10.1053/jhep.2001.24237.
42. Frevert U, Usynin I, Baer K, Klotz C. 2006. Nomadic or sessile: can Kupffer cells function as portals for malaria sporozoites to the liver? Cell Microbiol 8:1537-1546. http://dx.doi.org/10.1111/j.1462-5822 .2006.00777.x.
43. Wen-Yue X, Xing-Xiang W, Jie Q, Jian-Hua D, Fu-Sheng H. 2010. Plasmodium yoelii: influence of immune modulators on the development of the liver stage. Exp Parasitol 126:254-258. http://dx.doi.org/10.1016/j .exppara.2010.05.005.
44. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359-1365. http://dx.doi.org/10.1126/science.1241800.
45. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185:1155-1164. http://dx .doi.org/10.1086/339409.
46. Jin Y, Kebaier C, Vanderberg J. 2007. Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect Immun 75:5532-5539. http://dx.doi.org/10.1128 /IAI.00600-07.
47. Sissoko MS, Healy SA, Katile A, Kamate B, Samake Y, Sissoko K, Dolo A, Niare K, Niangaly A, Guindo MA, Gabriel E, Fay M, Zaidi I, Omaswa F, James E, Manoj A, Gunasekera A, Sim BKL, Billingsley P, Richie TL, Walther M, Hoffman SL, Duffy PE, Doumbo O. 2015. Safety and efficacy of direct venous inoculation with radiation attenuated Plasmodium falciparum NF54 sporozoites (PfSPZ vaccine) in healthy Malian adults (abstr 1636). Am J Trop Med Hyg 93(Suppl 4):278.
48. Richie TL, Billingsley PF, Sim BK, James ER, Chakravarty S, Epstein JE, Lyke KE, Mordmuller B, Alonso P, Duffy PE, Doumbo OK, Sauerwein RW, Tanner M, Abdulla S, Kremsner PG, Seder RA, Hoffman SL. 2015. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33:7452-7461.
49. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M, Stafford R, Ahumada A, Epstein JE, Sedegah M, Reyes S, Richie TL, Lyke KE, Edelman R, Laurens MB, Plowe CV, Sim BK. 2010. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6:97-106. http://dx.doi.org/10 .4161/hv.6.1.10396.
50. Yilmaz B, Portugal S, Tran TM, Gozzelino R, Ramos S, Gomes J, Regalado A, Cowan PJ, d'Apice AJ, Chong AS, Doumbo OK, Traore B, Crompton PD, Silveira H, Soares MP. 2014. Gut microbiota elicits a protective immune response against malaria transmission. Cell 159:1277- 1289. http://dx.doi.org/10.1016/j.cell.2014.10.053.
51. Eappen AG, Marquette M, De La Vega P, Li T, Billingsley PF, Sim BKL, Hoffman SL. 2015. In vitro produced P. falciparum sporozoites are as infectious as mosquito produced sporozoites in hepatocyte assays (abstr 561). Am J Trop Med Hyg 93(Suppl 4):145. http://dx.doi.org/10.4269 /ajtmh.14-0257.
52. Hafalla JC, Morrot A, Sano G, Milon G, Lafaille JJ, Zavala F. 2003. Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol 171:964-970. http://dx.doi.org/10.4049/jimmunol.171.2.964.
53. Cockburn IA, Chakravarty S, Overstreet MG, Garcia-Sastre A, Zavala F. 2008. Memory CD8+T cell responses expand when antigen presentation overcomes T cell self-regulation. J Immunol 180:64-71. http://dx.doi.org /10.4049/jimmunol.180.1.64.
54. Armiyanti Y, Nuryady MM, Arifianto RP, Nurmariana E, Senjarini K, Fitri LE, Sardjono TW. 2015. Detection of immunogenic proteins from Anopheles sundaicus salivary glands in the human serum. Rev Soc Bras Med Trop 48:410 - 416. http://dx.doi.org/10.1590/0037-8682 -0185-2015.
55. Rizzo C, Lombardo F, Ronca R, Mangano V, Sirima SB, Nebie I, Fiorentino G, Modiano D, Arca B. 2014. Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors. Parasit Vectors 7:549. http: //dx.doi.org/10.1186/s13071-014-0549-8.
56. Ali ZM, Bakli M, Fontaine A, Bakkali N, Vu Hai V, Audebert S, Boublik Y, Pages F, Remoue F, Rogier C, Fraisier C, Almeras L. 2012. Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites. Malar J 11:439. http://dx.doi.org/10 .1186/1475-2875-11-439.
57. Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, Poinsignon A, Sirima SB, Nebie I, Lombardo F, Remoue F, Coluzzi M, Petrarca V, Modiano D, Arca B. 2011. Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One 6:e17980. http://dx.doi.org/10.1371/journal .pone.0017980.
58. Choumet V, Attout T, Chartier L, Khun H, Sautereau J, Robbe-Vincent A, Brey P, Huerre M, Bain O. 2012. Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and salivaimmunized mice. PLoS One 7:e50464. http://dx.doi.org/10.1371/journal .pone.0050464.
59. Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. 2011. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9:451- 462. http://dx.doi.org/10.1016/j.chom.2011.05.008